Obesity Management
Digital Education Hubs
The field of obesity management is quickly evolving. New drug therapies and bariatric surgery are effective, but a larger understanding of social determinants, genetics, and the psychology behind obesity are proving to be essential pieces of the puzzle. Dismantling the myth that obesity is a lack of willpower or a “calories in, calories out” conundrum is necessary to shift the conversation away from placing blame and toward effective management.
CME/CE Activities
News Digest
CMHC Presents at ADA 2024: Key Findings and Insights
How To Overcome Clinical Disparities in Women with Chronic Kidney Disease (CKD)
5 Keys to Patient Education on GLP-1 RAs for Weight Loss
Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care
Cardiometabolic Health Congress Becomes First Organization to Offer Certification in Cardiometabolic Health
Expert Perspective: The Obesity Paradox with Salvatore Carbone, PhD
Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs
Cardiometabolic Health Congress Hosts 2023 Women’s Masterclass in California
Care in (un)Common Settings with Dr. Keith C. Ferdinand
article
Cardiometabolic Disease
Expert Highlights and Perspectives
Conversation about Obesity in T2DM
The Foundations of Managing Obesity in T2DM
- Adherence, Not Diet, Predict Success in Weight Loss
- Landmark Studies on Lifestyle Intervention: Diabetes Prevention Program
- Landmark Studies on Lifestyle Intervention: Look-Ahead
- Landmark Studies on Lifestyle Intervention: PROPEL
- Landmark Studies on Lifestyle Intervention: Translation to Clinical Care
Emerging Treatment Options for Long-Term Obesity Management
The Spectrum of Comprehensive Methods for Long-Term Weight Loss in T2DM
- More Weight Loss Provides More Clinical Benefit
- Current/ Old Treatment Paradigm for Cardiometabolic Diseases
- Medications for Weight Loss & Overview of Efficacy of FDA-Approved Treatments for Obesity
- Basic Rules for Prescribing Weight Loss Medications
- The Role of Metabolic Surgery in The Spectrum of Weight-Loss Interventions
- Bariatric Surgery Criteria
- Overview of Metabolic Surgery Procedures
Practical Approaches for Managing Obesity
Obesity, Inflammation, and Cardiovascular Risk
CMHC co-chair Christie Ballantyne, MD and Erin Michos, MD discuss the biology behind inflammation and obesity, obesity as an underappreciated but major CVD risk factor, and the ever-changing landscape of obesity treatment, with several approaches that have been recently approved or are in clinical development. They also share important practical pearls about the role of newer anti-obesity medications in conjunction with lifestyle for the long-term management of obesity. (Recorded at 2023 CMHC Spring, May 19, 2023.)
Perspectives & Discussions: NAFLD and NASH Screening, Diagnosis, and Emerging Treatments
Watch Drs. Eckel and Harrison discuss some additional perspectives on the screening, diagnosis and emerging treatment options for NASH. Recorded Dec.1, 2022.
Additional Expert Perspectives on Current Treatment Options for NASH
Watch CMHC faculty Dr. Barb discussing some practical pearls and the current treatment approaches for NASH. Recorded Dec.15, 2022.
Clinical Pearls for the Long-Term Management of Obesity : Expert Perspectives and Discussions
- Importance of recognizing and documenting obesity as a disease
- Common questions from patients and providers about obesity treatment
- Individualization of obesity treatment
- Tips to improve reimbursement and insurance coverage for obesity management
- The paradigm shifts in obesity management
CMHC Annual 2021 Obesity Management Panel
CMHC Chair Robert Eckel and faculty Holly Wyatt, MD and Michelle Look, MD recap the obesity session topics discussed at the 16th Annual CMHC, including the importance of assessing and addressing pre-obesity, patient motivation advice, and considerations for long-term weight maintenance and obesity management.
CMHC Annual 2021 Rare Obesity Disorders Panel
CMHC Chair Robert Eckel, MD, recaps the session on rare obesity disorders discussed at the 16th Annual CMHC with session presenters Joan Han, MD, and Clair Francomano, MD. The session discussed monogenic disorders of obesity, including leptin pathway defects and Alström syndrome, as well as practical pearls for screening, diagnosis, and treatment.
Resources
NAFLD and/or NASH
NAFLD = non-alcoholic fatty liver disease; NASH = non-alcoholic steatohepatitis
